Webinars

Timothy M. Miller, MD, PhD, (Washington University) will discuss VALOR, a global, Phase 3 clinical study sponsored by Biogen for eligible people living with SOD1-ALS. VALOR is being conducted to evaluate the safety and potential efficacy of the investigational drug tofersen in SOD1-ALS. 

NEALS Educational Webinar. As the COVID-19 situation continues to evolve, we know it is of particular concern for the ALS community, both for clinical care and research trials. To help address some of your questions and concerns, representatives from the NEALS leadership team will be hosting a second webinar on the impact of COVID-19 on ALS clinical research.

NEALS Educational Webinar. As the COVID-19 situation continues to evolve, we know it is of particular concern for the ALS community, both for clinical care and research trials.

This webinar provides introductory-level instruction on how to search for ALS clinical trials. You will learn what resources to use to find open ALS clinical trials and where to look for specific information such as eligibility criteria, trial site locations, and if traveling is required.

Presenter: Timothy Miller, MD, PhD. Novel gene-targeted therapies are being developed for ALS and other neurodegenerative diseases.  We will discuss how these drugs work and some of the research driving these clinical trials.